2024-04-012025-03-312025-03-31false09501868GLOW DENTAL LIMITED2025-10-23falseiso4217:GBPxbrli:pure095018682024-03-31095018682025-03-31095018682024-04-012025-03-31095018682023-03-31095018682024-03-31095018682023-04-012024-03-3109501868bus:SmallEntities2024-04-012025-03-3109501868bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3109501868bus:FullAccounts2024-04-012025-03-3109501868bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109501868core:WithinOneYear2025-03-3109501868core:AfterOneYear2025-03-3109501868core:WithinOneYear2024-03-3109501868core:AfterOneYear2024-03-3109501868core:ShareCapital2025-03-3109501868core:SharePremium2025-03-3109501868core:RevaluationReserve2025-03-3109501868core:OtherReservesSubtotal2025-03-3109501868core:RetainedEarningsAccumulatedLosses2025-03-3109501868core:ShareCapital2024-03-3109501868core:SharePremium2024-03-3109501868core:RevaluationReserve2024-03-3109501868core:OtherReservesSubtotal2024-03-3109501868core:RetainedEarningsAccumulatedLosses2024-03-3109501868core:LandBuildings2025-03-3109501868core:PlantMachinery2025-03-3109501868core:Vehicles2025-03-3109501868core:FurnitureFittings2025-03-3109501868core:OfficeEquipment2025-03-3109501868core:NetGoodwill2025-03-3109501868core:IntangibleAssetsOtherThanGoodwill2025-03-3109501868core:ListedExchangeTraded2025-03-3109501868core:UnlistedNon-exchangeTraded2025-03-3109501868core:LandBuildings2024-03-3109501868core:PlantMachinery2024-03-3109501868core:Vehicles2024-03-3109501868core:FurnitureFittings2024-03-3109501868core:OfficeEquipment2024-03-3109501868core:NetGoodwill2024-03-3109501868core:IntangibleAssetsOtherThanGoodwill2024-03-3109501868core:ListedExchangeTraded2024-03-3109501868core:UnlistedNon-exchangeTraded2024-03-3109501868core:LandBuildings2024-04-012025-03-3109501868core:PlantMachinery2024-04-012025-03-3109501868core:Vehicles2024-04-012025-03-3109501868core:FurnitureFittings2024-04-012025-03-3109501868core:OfficeEquipment2024-04-012025-03-3109501868core:NetGoodwill2024-04-012025-03-3109501868core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109501868core:ListedExchangeTraded2024-04-012025-03-3109501868core:UnlistedNon-exchangeTraded2024-04-012025-03-3109501868core:MoreThanFiveYears2024-04-012025-03-3109501868core:Non-currentFinancialInstruments2025-03-3109501868core:Non-currentFinancialInstruments2024-03-3109501868dpl:CostSales2024-04-012025-03-3109501868dpl:DistributionCosts2024-04-012025-03-3109501868core:LandBuildings2024-04-012025-03-3109501868core:PlantMachinery2024-04-012025-03-3109501868core:Vehicles2024-04-012025-03-3109501868core:FurnitureFittings2024-04-012025-03-3109501868core:OfficeEquipment2024-04-012025-03-3109501868dpl:AdministrativeExpenses2024-04-012025-03-3109501868core:NetGoodwill2024-04-012025-03-3109501868core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109501868dpl:GroupUndertakings2024-04-012025-03-3109501868dpl:ParticipatingInterests2024-04-012025-03-3109501868dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3109501868core:ListedExchangeTraded2024-04-012025-03-3109501868dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3109501868core:UnlistedNon-exchangeTraded2024-04-012025-03-3109501868dpl:CostSales2023-04-012024-03-3109501868dpl:DistributionCosts2023-04-012024-03-3109501868core:LandBuildings2023-04-012024-03-3109501868core:PlantMachinery2023-04-012024-03-3109501868core:Vehicles2023-04-012024-03-3109501868core:FurnitureFittings2023-04-012024-03-3109501868core:OfficeEquipment2023-04-012024-03-3109501868dpl:AdministrativeExpenses2023-04-012024-03-3109501868core:NetGoodwill2023-04-012024-03-3109501868core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109501868dpl:GroupUndertakings2023-04-012024-03-3109501868dpl:ParticipatingInterests2023-04-012024-03-3109501868dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109501868core:ListedExchangeTraded2023-04-012024-03-3109501868dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109501868core:UnlistedNon-exchangeTraded2023-04-012024-03-3109501868core:NetGoodwill2025-03-3109501868core:IntangibleAssetsOtherThanGoodwill2025-03-3109501868core:LandBuildings2025-03-3109501868core:PlantMachinery2025-03-3109501868core:Vehicles2025-03-3109501868core:FurnitureFittings2025-03-3109501868core:OfficeEquipment2025-03-3109501868core:AfterOneYear2025-03-3109501868core:WithinOneYear2025-03-3109501868core:ListedExchangeTraded2025-03-3109501868core:UnlistedNon-exchangeTraded2025-03-3109501868core:ShareCapital2025-03-3109501868core:SharePremium2025-03-3109501868core:RevaluationReserve2025-03-3109501868core:OtherReservesSubtotal2025-03-3109501868core:RetainedEarningsAccumulatedLosses2025-03-3109501868core:NetGoodwill2024-03-3109501868core:IntangibleAssetsOtherThanGoodwill2024-03-3109501868core:LandBuildings2024-03-3109501868core:PlantMachinery2024-03-3109501868core:Vehicles2024-03-3109501868core:FurnitureFittings2024-03-3109501868core:OfficeEquipment2024-03-3109501868core:AfterOneYear2024-03-3109501868core:WithinOneYear2024-03-3109501868core:ListedExchangeTraded2024-03-3109501868core:UnlistedNon-exchangeTraded2024-03-3109501868core:ShareCapital2024-03-3109501868core:SharePremium2024-03-3109501868core:RevaluationReserve2024-03-3109501868core:OtherReservesSubtotal2024-03-3109501868core:RetainedEarningsAccumulatedLosses2024-03-3109501868core:NetGoodwill2023-03-3109501868core:IntangibleAssetsOtherThanGoodwill2023-03-3109501868core:LandBuildings2023-03-3109501868core:PlantMachinery2023-03-3109501868core:Vehicles2023-03-3109501868core:FurnitureFittings2023-03-3109501868core:OfficeEquipment2023-03-3109501868core:AfterOneYear2023-03-3109501868core:WithinOneYear2023-03-3109501868core:ListedExchangeTraded2023-03-3109501868core:UnlistedNon-exchangeTraded2023-03-3109501868core:ShareCapital2023-03-3109501868core:SharePremium2023-03-3109501868core:RevaluationReserve2023-03-3109501868core:OtherReservesSubtotal2023-03-3109501868core:RetainedEarningsAccumulatedLosses2023-03-3109501868core:AfterOneYear2024-04-012025-03-3109501868core:WithinOneYear2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109501868core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109501868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109501868core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109501868core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109501868core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109501868bus:Director12024-04-012025-03-31

GLOW DENTAL LIMITED

Registered Number
09501868
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

GLOW DENTAL LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Dr Hooman Sanaty

Registered Address

87 Northcote Road
Battersea
SW11 6PL

Registered Number

09501868 (England and Wales)
GLOW DENTAL LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets364,167174,167
Tangible assets4100,535125,707
164,702299,874
Current assets
Stocks54,9504,950
Debtors6346,2481,943,398
Cash at bank and on hand270,513349,776
621,7112,298,124
Creditors amounts falling due within one year7(729,219)(721,161)
Net current assets (liabilities)(107,508)1,576,963
Total assets less current liabilities57,1941,876,837
Creditors amounts falling due after one year8(6,934)(13,340)
Provisions for liabilities10(25,134)(31,500)
Net assets25,1261,831,997
Capital and reserves
Called up share capital25,12525,125
Profit and loss account11,806,872
Shareholders' funds25,1261,831,997
The financial statements were approved and authorised for issue by the Director on 23 October 2025, and are signed on its behalf by:
Dr Hooman Sanaty
Director
Registered Company No. 09501868
GLOW DENTAL LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows: Short leasehold - Straight line over 8 years Plant, machinery & Equipment - 15% on cost Computer equipment - 15% on cost
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year1110
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 241,100,0001,100,000
At 31 March 251,100,0001,100,000
Amortisation and impairment
At 01 April 24925,833925,833
Charge for year110,000110,000
At 31 March 251,035,8331,035,833
Net book value
At 31 March 2564,16764,167
At 31 March 24174,167174,167
4.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 April 2437,010351,32652,307440,643
Revaluations-8,353-8,353
At 31 March 2537,010359,67952,307448,996
Depreciation and impairment
At 01 April 2437,010236,60641,320314,936
Charge for year-29,3474,17833,525
At 31 March 2537,010265,95345,498348,461
Net book value
At 31 March 25-93,7266,809100,535
At 31 March 24-114,72010,987125,707
5.Stocks

2025

2024

££
Other stocks4,9504,950
Total4,9504,950
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables345,654-
Other debtors-1,942,060
Prepayments and accrued income5941,338
Total346,2481,943,398
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables64,21958,462
Bank borrowings and overdrafts8,9869,777
Taxation and social security161,114163,208
Finance lease and HP contracts6,4069,392
Other creditors3,98246,849
Accrued liabilities and deferred income484,512433,473
Total729,219721,161
8.Creditors: amounts due after one year

2025

2024

££
Other creditors6,93413,340
Total6,93413,340
9.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts6,93413,340
10.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)25,13431,500
Total25,13431,500
11.Directors advances, credits and guarantees
In Other Creditors, it includes a balance of £2,910 Cr (2024: 41,022 Cr) ) at year-end related to the director, Hooman Sanaty.
12.Related party transactions
Included in "Other Debtor" an amount of £345,654 was owed by a group undertaking, Glowmed Limited.